Sfoglia per Autore
Difference in health related quality of life of chronic liver diseases and general population
2017 Cortesi, P; Conti, S; Scalone, L; Ciaccio, A; Okolicsanyi, S; Rota, M; Belli, L; Cesana, G; Strazzabosco, M; Mantovani, L
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis
2017 Ciaccio, A; Cortesi, P; Bellelli, G; Rota, M; Conti, S; Okolicsanyi, S; Rota, M; Cesana, G; Mantovani, L; Annoni, G; Strazzabosco, M
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
2017 Zavaglia, C; Okolicsanyi, S; Cesarini, L; Mazzarelli, C; Pontecorvi, V; Ciaccio, A; Strazzabosco, M; Belli, L
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study
2015 Fabris, L; Ciaccio, A; Okolicsanyi, S; Rota, M; Cortesi, P; Buonocore, M; Gemma, M; Giani, P; Belli, L; Fagiuoli, S; Scalone, L; Valsecchi, M; Mantovani, L; Strazzabosco, M
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study
2015 Fabris, L; Ciaccio, A; Okolicsanyi, S; Rota, M; Cortesi, P; Buonocore, M; Gemma, M; Giani, P; Belli, L; Fagiuoli, S; Scalone, L; Valsecchi, M; Mantovani, L; Strazzabosco, M
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon?
2015 Ciaccio, A; Okolicsanyi, S; Rota, M; Cortesi, P; De Salvia, S; Gemma, M; Vinci, M; Mantovani, L; Belli, L; Strazzabosco, M
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study
2015 Fabris, L; Ciaccio, A; Okolicsanyi, S; Rota, M; Cortesi, P; Belli, L; Fagiuoli, S; Scalone, L; Cesana, G; Mantovani, L; Strazzabosco, M
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1
2015 Ciaccio, A; Cortesi, P; Bellelli, G; Rota, M; Rota, M; Mantovani, L; Annoni, G; Strazzabosco, M
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients?
2015 Cortesi, P; Ciaccio, A; Bellelli, G; Rota, M; Rota, M; Cesana, G; Mantovani, L; Annoni, G; Strazzabosco, M
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients?
2015 Cortesi, P; Ciaccio, A; Bellelli, G; Rota, M; Rota, M; Conti, S; Mantovani, L; Annoni, G; Strazzabosco, M
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis
2015 Ciaccio, A; Cortesi, P; Bellelli, G; Rota, M; Rota, M; Okolicsanyi, S; Mantovani, L; Annoni, G; Strazzabosco, M
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options
2015 Cortesi, P; Ciaccio, A; Rota, M; Lim, J; De Salvia, S; Okolicsanyi, S; Vinci, M; Belli, L; Mantovani, L; Strazzabosco, M
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis
2015 Ciaccio, A; Cortesi, P; Bellelli, G; Rota, M; Okolicsanyi, S; Rota, M; Mantovani, L; Annoni, G; Strazzabosco, M
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis
2015 Cortesi, P; Mantovani, L; Ciaccio, A; Rota, M; Mazzarelli, C; Cesana, G; Strazzabosco, M; Belli, L
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study
2014 Rota, M; Okolicsanyi, S; Ciaccio, A; Gemma, M; Gentiluomo, M; Grisolia, A; Cortesi, P; Scalone, L; Mantovani, L; Cesana, G; Valsecchi, M; Pontisso, P; Mondelli, M; Marchesini, G; Fabris, L; Mazzaferro, V; Burra, P; Colledan, M; Fagiuoli, S; Belli, L; Strazzabosco, M
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options
2014 Cortesi, P; Ciaccio, A; Rota, M; Salvia, S; Vinci, M; Belli, L; Lim, J; Mantovani, L; Strazzabosco, M
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis
2014 Cortesi, P; Ciaccio, A; Rota, M; De Salvia, S; Okolicsanyi, S; Vinci, M; Belli, L; Lim, J; Mantovani, L; Strazzabosco, M
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia
2014 Cortesi, P; Mantovani, L; Ciaccio, A; Rota, M; Cesana, G; Strazzabosco, M; Belli, L
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study)
2014 Okolicsanyi, S; Ciaccio, A; Rota, M; Gentiluomo, M; Gemma, M; Grisolia, A; Cortesi, P; Scalone, L; Mantovani, L; Pontisso, P; Burra, P; Fabris, L; Mondelli, M; Colledan, M; Fagiuoli, S; Valsecchi, M; Cesana, G; Belli, L; Strazzabosco, M
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study)
2014 Okolicsanyi, S; Ciaccio, A; Rota, M; Gentiluomo, M; Gemma, M; Grisolia, A; Cortesi, P; Scalone, L; Mantovani, L; Pontisso, P; Burra, P; Fabris, L; Mondelli, M; Colledan, M; Fagiuoli, S; Valsecchi, M; Cesana, G; Belli, L; Strazzabosco, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile